7
Disclosures
Jan 16, 2026 — Mar 25, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 25 Other SymBio Pharmaceuticals: SymBio Pharma Shareholders Approve Key Resolutions at Annual Meeting PDF
Mar 24 Admin SymBio Pharmaceuticals: Appoints New Board Members and Executives PDF
Mar 24 Dividend SymBio Pharmaceuticals: Issues 35,000 Stock Options PDF
Mar 24 Dividend SymBio Pharmaceuticals: Issues 9,000 Stock Options PDF
Mar 23 Earnings SymBio Pharmaceuticals: Adjusts Bond Conversion and Repayment Status; Funds Reallocation Announced PDF
Mar 17 Other Completes First Patient Enrollment in Global Phase III Trial for AdV Infections Post-Hematopoietic Stem Cell Transplantation PDF
Mar 16 Other Secures Patent for IV BCV in Lymphoma Treatment PDF

Disclosure Types

Other: 3 Dividend: 2 Admin: 1 Earnings: 1